Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study by Lopresti, M. L., Bian, J. J., Sakr, B. J., Strenger, R. S., Legare, R. D., Fenton, M., Witherby, S. M., Dizon, D. S., Pandya, S. V., Stuckey, A. R., Edmondson, D. A., Gass, J. S., Emmick, C. M., Graves, T. A., Cutitar, M., Olszewski, A. J., Sikov, W. M.

Get full text

Abstract P2-16-19: Neoadjuvant weekly paclitaxel (wP) and carboplatin (Cb) with trastuzumab (T) and pertuzumab (P) in HER2-positive breast cancer (H+BC): A Brown University oncolog... by Lopresti, Mary Lorraine, Bian, Jessica J., Sakr, Bachir J, Strenger, Rochelle S, Legare, Robert D., Fenton, Mary Anne, Witherby, Sabrina M, Dizon, Don S, Pandya, Sonali V, Stuckey, Ashley R, Edmondson, David A, Gass, Jennifer S, Emmick, Christine M, Graves, Theresa A, Cutitar, Marlene, Olszewski, Adam J, Sikov, William M

Get full text